XML 155 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF (LOSS) INCOME - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Revenues $ 3,308.9 $ 3,485.9 $ 3,580.7
Cost of revenues 2,134.4 2,109.9 2,118.2
Gross profit 1,174.5 1,376.0 1,462.5
Selling, general and administrative expenses 1,055.1 1,165.6 1,395.6
Goodwill impairment 228.3 358.7 65.0
Divestiture losses, net of gains 103.0 12.8 9.5
(Loss) income from operations (211.9) (161.1) (7.6)
Interest expense, net (118.3) (106.0) (93.7)
Loss on early extinguishment of debt (23.1)    
Other expense, net (9.5) (8.3) (6.6)
Loss before income taxes (362.8) (275.4) (107.9)
Income tax benefit 16.8 29.8 150.9
Net (loss) income (346.0) (245.6) 43.0
Net (income) loss attributable to noncontrolling interests (0.8) 0.9 (0.6)
Net (loss) income attributable to Stericycle, Inc. (346.8) (244.7) 42.4
Mandatory convertible preferred stock dividend   (25.5) (36.3)
Gain on repurchase of preferred stock   16.9 17.3
Net (loss) income attributable to Stericycle, Inc. common shareholders $ (346.8) $ (253.3) $ 23.4
(Loss) Earnings per common share attributable to Stericycle, Inc. common shareholders:      
Basic $ (3.81) $ (2.91) $ 0.27
Diluted $ (3.81) $ (2.91) $ 0.27
Weighted average number of common shares Outstanding:      
Basic 91.0 87.1 85.3
Diluted 91.0 87.1 85.6